Cleared Traditional

TissueTak device (K203117) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K203117 · Via Surgical , Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2021
Decision
83d
Days
Class 2
Risk

K203117 is an FDA 510(k) clearance for the TissueTak device. Classified as Staple, Implantable (product code GDW), Class II - Special Controls.

Submitted by Via Surgical , Ltd. (Amirim, IL). The FDA issued a Cleared decision on January 7, 2021 after a review of 83 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4750 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Via Surgical , Ltd. devices

Submission Details

510(k) Number K203117 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 16, 2020
Decision Date January 07, 2021
Days to Decision 83 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 115d · This submission: 83d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GDW Staple, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Orly Maor
Orly Maor

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GDW Staple, Implantable

All 128
Devices cleared under the same product code (GDW) and FDA review panel - the closest regulatory comparables to K203117.
Titan SGS
K210278 · Standard Bariatrics · Apr 2021
Mirus Circular Stapler, Mirus Linear Cutter and Reload, Mirus Hemorrhoidal Circular Stapler, Mirus Linear Stapler and Reload
K200320 · M/s. Meril Endo Surgery Private Limited. · Feb 2021
EEA Circular Stapler with Tri-Staple Technology
K202507 · Covidien · Jan 2021
Disposable Powered Articulating Endoscopic Linear Cutter Stapler & Reloads
K202467 · Fengh Medical Co., Ltd. · Dec 2020
GIA Stapler with Tri-Staple Technology
K202701 · Covidien · Dec 2020
Tri-Staple 2.0 Reloads
K202864 · Covidien · Oct 2020